Nascent Biotech, Inc. (NBIO)
OTCMKTS: NBIO · Delayed Price · USD
0.0500
-0.0050 (-9.09%)
Jul 26, 2024, 3:47 PM EDT - Market closed
Nascent Biotech Market Cap
Nascent Biotech has a market cap or net worth of $8.61 million as of July 26, 2024. Its market cap has increased by 13.30% in one year.
Market Cap
8.61M
Enterprise Value
8.36M
1-Year Change
13.30%
Ranking
n/a
Category
Stock Price
$0.05
Market Cap Chart
Since July 26, 2019, Nascent Biotech's market cap has increased from $6.55M to $8.61M, an increase of 31.52%. That is a compound annual growth rate of 5.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 8.53M | -70.50% |
| Dec 29, 2023 | 28.92M | 20.99% |
| Dec 30, 2022 | 23.90M | 334.96% |
| Dec 31, 2021 | 5.49M | 150.09% |
| Dec 31, 2020 | 2.20M | -53.90% |
| Dec 31, 2019 | 4.77M | -27.20% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 817.23B |
| Novo Nordisk | 593.43B |
| UnitedHealth Group | 515.19B |
| Johnson & Johnson | 376.12B |
| Merck & Co. | 318.93B |
| AbbVie | 311.16B |
| AstraZeneca | 247.14B |
| Thermo Fisher | 219.38B |